CMIC Group


Contract research, development and manufacturing organization providing end-to-end services across preclinical, clinical, regulatory, manufacturing and commercial stages. Offers CRO, CDMO, bioanalysis, regulatory consulting, pharmacovigilance, real-world evidence and digital health solutions with operational focus in Japan and the wider Asia-Pacific region.

Industries

health-care
manufacturing
pharmaceutical

Nr. of Employees

large (251-1000)

CMIC Group

Hoffman Estates, Illinois, United States, North America


Products

Cloud vaccination information management system

Cloud-based system for recording vaccination details, scheduling and follow-up alerts to support mass vaccination programs.


Services

End-to-end clinical trial services including protocol development, project management, site management, monitoring and patient recruitment with APAC coverage.

Local operational oversight, regulatory liaison and investigator engagement for sponsors conducting trials in Japan and other APAC countries; fulfils in-country caretaker regulatory responsibilities.

Site network and medical-concierge services providing coverage and engagement across a large network of medical institutions in Japan to support site selection, activation and site liaison.

GLP/nonclinical study execution, toxicology/safety pharmacology and regulated bioanalytical testing for small and large molecules.

Formulation, process development, clinical batch manufacturing, technology transfer, CMC documentation and commercial manufacturing including sterile/parenteral and oral dosage forms.

Regulatory submissions, market feasibility, designation pathway support and local market-entry strategy for Japan and APAC.

View All Services

Expertise Areas

  • Clinical trial management (Phase I–IV) in APAC
  • In-country site operations and ICCC responsibilities
  • Clinical site network and site-management (SMO) services in Japan
  • Decentralized, hybrid and virtual trial models
  • Show More (12)

Key Technologies

  • Liquid chromatography–tandem mass spectrometry (LC-MS/MS)
  • Lipidomics by LC-MS
  • PK and ADA immunoassays
  • Oligonucleotide assay development
  • Show More (15)

News & Updates

White paper describing trends and operational considerations for decentralized clinical trials in Japan.

Global CRO Council recommendations and interpretation of EMA guidance on bioanalytical method validation.

Webinar on mRNA therapeutic approaches, preclinical considerations and development prospects.

Video discussion of Japan market environment, regulatory strategies and market entry considerations.

Recorded session covering regulatory framework, initial regulatory steps and clinical development considerations for cell and gene therapies in Japan.

Webinar on market dynamics, regulatory differences and strategies for clinical development in Japan and China, including HEOR and quality perspectives.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.